onasemnogene abeparvovec-xioi
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:activities |
gene replacement therapy
|
| gptkbp:approves |
gptkb:2019
gptkb:FDA |
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:developed_by |
gptkb:Ave_Xis
|
| https://www.w3.org/2000/01/rdf-schema#label |
onasemnogene abeparvovec-xioi
|
| gptkbp:manager |
intravenous
|
| gptkbp:marketed_as |
gptkb:Zolgensma
|
| gptkbp:serves |
gptkb:DJ
|
| gptkbp:targets |
gptkb:SMA_type_1
|
| gptkbp:bfsParent |
gptkb:Zolgensma
|
| gptkbp:bfsLayer |
4
|